A 53-year old female patient, who presented with retrosternal pain, which could be ascribed to reflux oesophagitis and gastritis, furthermore stated recurrent palpitations, sweating and the feeling of uneasiness. In routine laboratory investigation hyperthyroidism and hypercalcaemia were detected. Further testing revealed elevated TSH receptor antibodies and a parathyroid hormone level within the normal range. Scintigraphically a homogeneous, but increased uptake was found. In ultrasonography guided fine needle aspiration biopsy of a nodule parathyroid hormone was verifiable by immunochemical means. Under thyrostatic treatment with carbimazole the patient became euthyroid, simultaneous a decrease of serum calcium levels could be observed. Parathyroid hormone level remained in normal range. After confirmation of Graves´disease and adenoma of the parathyroid gland parathyroidectomy in combination with near total resection of the thyroid gland was performed. In conclusions concomitant Graves' disease and primary hyperparathyroidism is rare, but should be considered in case of persisting hypercalcaemia after the patient became euthyroid again, when parathyroid hormone level is in normal range or elevated. Thus a potentially required second operation can be avoided. By ultrasonography guided fine needle aspiration biopsy and immunochemical processing adenomas of parathyroid glands can be localized preoperatively.
Introduction
Several cases of simultaneous hyperthyroidism and primary hyperparathyroidism have been published [1] . Some authors have described the occurrence of hyperparathyroidism following treatment of Graves' disease with radioactive iodine [2] or in cases adenomas of the parathyroid gland found in the course of thyroidectomy or following histopathological processing [1] . Because hyperthyroidism is often associated with hypercalcaemia due to increased bone metabolism [3] , the simultaneous elevation or at least inability of thyrostatic treatment to reduce the level of parathyroid hormone level indicates coexisting hyperparathyroidism [4] . Here, we describe a case of preoperatively confirmed asymptomatic primary hyperparathyroidism with a normal parathyroid hormone level, which was caused by adenoma of the parathyroid gland and coexisting Graves' disease due thyroid stimulating hormone (TSH) receptor-activating antibodies.
Case report
A 53-year old female patient presented with retrosternal and epigastric pain. She also stated that she suffered from recurrent palpitations, sweating, and a feeling of unease. She had a normal appetite, steady body weight, and did not show changes in defecation, micronutrition, or mental health. Eight weeks before, she had been diagnosed with gastric ulcer and treated to eradicate Helicobacter pylori. In addition, her history included hepatitis 30 years before as well as appendectomy and occlusion of the fallopian tubes.
The patient presented with a normal mental status, a height of 160 cm, body weight of 66 kg, and body mass index 25.8. She had a blood pressure of 160/90 mmHg, heart rate of 102 beats per minute (regular), respiration rate of 14 per min, and temperature of 36.6 • C. Further physical examination revealed no pathological findings. There were no trophic alterations in her skin, hair, or nails. Also, she showed no signs of orbitopathy.
Blood tests showed suppressed thyrotropin (TSH) (< 0.03 mU/L; normal range = 0.30 -4.00 mU/L), elevated total triiodothyronine (5.0 nmol/L; normal range = 0.7 -2.4 nmol/L), free thyroxine (49,6 pmol/L; normal range 9,0 -26,0 pmol/L), and elevated TSH receptor antibodies (6.9 U/L; normal range 0,0 -1,0 U/L).
The total serum calcium was 2.7 mmol/L (in a control sample 2.9 mmol/L; normal range = 2.1 -2.6 mmol/L), inorganic phosphate was 3.5 mg/dl (normal range = 2.5 -4.8 mg/dl) and intact parathyroid hormone 4.5 pmol/L; normal range = 1.0 -7.0 pmol/L).
The 24-h collected urine (3800 ml) showed a creatinine clearance of 163 ml/min (normal range = 70 -160 ml/min), calcium excretion of 16.3 mmol per 24 h (normal range < 10 mmol per 24 h), and a phosphate excretion of 1,0 g per 24 h (normal range = 0.5 -1.4 g per 24 h).
The serum alkaline phosphatase level was 142 U/L (normal range < 100 U/L), CRP 20.1 mg/L (normal range < 5 mg/l), angiotensin converting enzyme 94 U/L (normal range = =8 -52 U/L), and leukocyte count 15.7 per nl (normal range = 4.00 -10.00 per nl). Other routine laboratory parameters, including sodium, potassium, chloride, total protein, albumin, creatinine, urea, and other aspects of the haemogram were largely within normal ranges.
Electrocardiography showed sinus tachycardia, a heart rate of 104 beats per minute, a left anterior hemiblock, and normal repolarization.
Ultrasonography revealed a slightly enlarged thyroid gland (total 22.2 ml; right lobe 14.3 ml; left lobe 7.9 ml) with an inhomogeneous reflex pattern. The ultrasonography also revealed the presence of a hypoecho nodule (0.8 x 0.6 x 1.3 cm) dorsal of the left lower pole. Fine-needle biopsy of this nodule showed tissue from a parathyroid gland with a positive immunohistochemical staining for parathyroid hormone. Staining for thyroglobulin was negative. No signs of malignancy could be detected.
Scintigraphy of the thyroid gland with 99m-Tc-Pertechnetate showed a homogeneous uptake that was elevated to 4.4%. Scintigraphy of the parathyroid glands with 99m-Tc-Tetrofosmin revealed no pathological findings.
Bone scintigraphy did not reveal signs of osteolysis, and osteodensitometry of the lumbar spine using DPX showed a T-score of -2.0 SD based on the normal collective of young adults, indicating distinctive osteopenia.
Postoperative histological examination showed an enlarged adenomatous thyroid gland with signs of autoimmune thyroiditis. The nodule dorsal to the left lower pole turned out to be a parathyroid adenoma (1.3 cm in diameter), with a solid to small follicular structure. On the adenoma margin, there was preexisting regressively transformed parathyroid tissue containing 40% fatty tissue.
Due to the retrosternal pain that lead to hospitalization for an acute coronary syndrome, serial electrocardiography and repeat measurements of myocardial necrosis markers (troponin and CK-MB) were conducted, but no signs of myocardial ischemia were found. The pain could be explained by gastroesophageal reflux, which was confirmed by endoscopy, combined with antrum gastritis and the established gastric ulcer, which was treated with the proton-pump inhibitor pantoprazole. In addition, the patient reported additional discomfort due to palpitations, tachycardia, sweating, and uneasiness. Analysis of blood samples revealed thyrotoxicosis. Ultrasonography and scintigraphy showed a slightly enlarged thyroid gland with an inhomogeneous reflex pattern and a homogeneous but elevated activity uptake of 4.4%. This and the finding of elevated TSH receptor antibodies (6.9 IU/L) confirmed the diagnosis of Graves' disease.
Furthermore hypercalcaemia accompanied by normal phosphate, total protein, and albumin levels was detected. The parathyroid hormone level was within the normal range. Analysis of calcium and phosphate excretion in 24-h collected urine showed that calcium excretion was elevated but phosphate excretion was normal. The ratio of calcium clearance to creatinine clearance was 0.025, and scores above 0.01 argue against the existence of familial hypocalciuric hypercalcaemia.
Examination of bone metabolism by scintigraphically did not suggest localized osteolysis, but remarkable osteopenia was found by osteodensitometry, and serum alkaline phosphatase was slightly elevated.
Hypercalcaemia for reasons besides thyrotoxicosis, including cancer, multiple myeloma (protein electrophoresis and immunofixation in blood and urine were normal), familial hypocalciuric hypercalcaemia (no evidence of hypocalciuria), or medication were not found. Hypercalcaemia could have been caused by sarcoidosis as suggested by an elevated serum ACE level, but this was unlikely because chest radiography was inconspicuous and there was no sign of fever, arthritis, or lymphadenopathy. After confirmation of the diagnosis of Graves' disease, the patient received thyrostatic treatment with carbimazole at an initial dosage of 30 mg per day, followed by gradual reduction. Because the serum calcium levels did not normalize after re-establishment of euthyroidism ( Fig. 1 ) and because the parathyroid hormone level was not suppressed, it appeared that there was a dysfunction in the control circuit for parathyroid hormone, suggesting the existence of primary hyperparathyroidism in addition to Graves' disease. There was no evidence for current or former nephrolithiasis. Because there were no further symptoms of primary hyperparathyroidism due to amyasthenia or mental disorders and because the gastritis leading to hospitalization and the healed gastric ulcer suggested infection with H. pylori rather than hyperparathyroidism, the primary hyperparathyroidism was classified as asymptomatic. A fine needle biopsy of an ultrasonographically visible hypoecho structure dorsal to the left lower pole of the thyroid gland with a maximum diameter of 1.3 cm was performed without complications. Immunohistochemical processing of the aspirate showed positive staining for parathyroid hormone (Fig. 2) but negative staining for thyroglobulin. Together, the combination of an enlarged parathyroid gland, hypercalcaemia, and inability to suppress the parathyroid hormone level, suggested an adenoma of the parathyroid gland with mild primary hyperparathyroidism. Four months after confirmation of the diagnosis, a near total thyroidectomy in combination with sinistral parathyroidectomy was performed under euthyroid conditions. Histological examination of the extracted organs confirmed both presumed diagnoses (Fig.  3) . The follow-up showed no complications and a normalization of the serum calcium level (Fig. 1) . 
Discussion
Asymptomatic primary hyperparathyroidism is a common incidental finding, but because concomitant hyperthyroidism can cause problems in diagnosis, any newly diagnosed hypercalcaemia requires further investigation. When serum total protein, especially serum albumin, is within the normal range, cancer and hyperparathyroidism are the most frequent causes and must be explored first. Hyperparathyroidism can be diagnosed in most cases by the presence of hypercalcaemia with elevated or at least unsuppressed parathyroid hormone and low serum phosphate. Analyzing calcium excretion in 24-h collected urine and systematic anamnesis allows exclusion of familial hypocalciuric hypercalcaemia.
In concomitant hyperthyroidism, the interpretation of hypercalcaemia and hypercalciuria is more difficult because of disturbances in calcium phosphate metabolism. Ultrasound-guided fine-needle biopsy of parathyroid lesions helps identify parathyroid adenomas preoperatively and prevent complications, especially before repeat operations [5] . In most cases, parathyroid adenoma and parathyroid hyperplasia can be distinguished from the biopsy, especially because of the small follicular structure and the pleomorphic nuclei present in adenomas [6] . Guided by immunohistochemical staining for parathyroid hormone and thyroglobulin, the aspirates can easily distinguish proximal structures, especially thyroid tissue, which also contains follicular structures.
The combined presentation of primary hyperparathyroidism and Graves' disease is very rare, but there are some published cases. The earliest was a report from 1936 [7] . The most effective treatment for the mentioned constellation of symptoms and for hyperthyroidism following regressive thyroid adenomatosis accompanied by primary hyperthyroidism is combined resection of the thyroid gland and the affected parathyroid glands.
In approximately 22% of cases of hyperthyroidism, concomitant hypercalcaemia is present [3] . This is due to increased calcium mobilization from the bone and, in most cases, it remains asymptomatic [8, 9] . This results in increased calcium excretion in the urine and normally leads to a negative calcium balance. Hypercalcaemia in hyperthyroidism normally accompanies a decreased or normal parathyroid hormone level, and there does not seem to be a relationship between hyperthyroidism and hyperparathyroidism [10] . Thus, the two conditions must be treated separately. Most likely, there is a synergistic effect of concomitant hyperthyroidism and primary hyperparathyroidism on osteoclastic bone conversion, causing hypercalcaemia, which in turn suppresses parathyroid hormone secretion.
This mechanism can explain reports of a decline in serum calcium and the increase in the level of parathyroid hormone after reestablishment of euthyroidism [1, 4, [9] [10] [11] . The current case also showed a decrease in serum calcium after the reestablishment of euthyroidism (Fig. 1) , but there was an increase in the level of parathyroid hormone, even though the initial level was within the normal range and an increase could not be detected for up to 10 days after the initiation of thyrostatic treatment. It should be noted that the control of the parathyroid level may have been carried out too soon, and, unfortunately, a later evaluation was not conducted.
In conclusion, every newly diagnosed hypercalcaemia requires further clarification. Persistent hypercalcaemia after reestablishment of euthyroidism in hyperthyroid patients may indicate concomitant hyperparathyroidism if the parathyroid hormone level is not lowered. In this case, ultrasonography should be formed to search for hypoecho structures in the parathyroid glands. These structures can easily be biopsied and differentiated by immunohistochemistry. If there is evidence of concomitant parathyroid adenoma, the best treatment is a combined resection of the thyroid and parathyroid. This procedure can avoid the need for a second operation, which naturally carries an increased risk of complication.
